Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Borys

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Archives of Allergy and Applied Immunology|January 1, 1986
Function of phagocytes in experimentally induced colitis in rabbits. II. The Shwartzman phenomenon in the colonA Hermanowicz, A Hermel, A Nowak, et al.
Brain Research. Developmental Brain Research|January 27, 2004
Prenatal cocaine administration increases glutathione and alpha-tocopherol oxidation in fetal rat brainJack W Lipton, Sandeep Gyawali, Ewa D Borys, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)|December 20, 2005
Trends in the incidence of the free wall cardiac rupture in acute myocardial infarction. observational study: experience of a single centerB Sobkowicz, L Lenartowska, M Nowak, et al.
Vaccine|May 25, 2019
Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants - Results from a randomized, double-blind vaccine trialH Nieminen, H Rinta-Kokko, J Jokinen, et al.
Vaccine|September 4, 2017
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2-17-year-old children with asplenia or splenic dysfunction: A phase 3 studyL Szenborn, I V Osipova, H Czajka, et al.
The Nigerian Postgraduate Medical Journal|March 18, 2014
Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian Infants: a randomised trialO O Odusanya, Y A Kuyinu, O A Kehinde, et al.
The Lancet. Respiratory Medicine|August 16, 2014
Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trialA A Palmu, J Jokinen, H Nieminen, et al.
Plos One|August 21, 2015
VSX2 and ASCL1 Are Indicators of Neurogenic Competence in Human Retinal Progenitor CulturesLynda S Wright, Isabel Pinilla, Jishnu Saha, et al.
Human Vaccines & Immunotherapeutics|December 1, 2015
Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized studyA Odutola, M O Ota, E O Ogundare, et al.
American Journal of Human Genetics|January 29, 2019
Gene Augmentation and Readthrough Rescue Channelopathy in an iPSC-RPE Model of Congenital BlindnessPawan K Shahi, Dalton Hermans, Divya Sinha, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Archives of Allergy and Applied Immunology|January 1, 1986
Function of phagocytes in experimentally induced colitis in rabbits. II. The Shwartzman phenomenon in the colonA Hermanowicz, A Hermel, A Nowak, et al.
Brain Research. Developmental Brain Research|January 27, 2004
Prenatal cocaine administration increases glutathione and alpha-tocopherol oxidation in fetal rat brainJack W Lipton, Sandeep Gyawali, Ewa D Borys, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)|December 20, 2005
Trends in the incidence of the free wall cardiac rupture in acute myocardial infarction. observational study: experience of a single centerB Sobkowicz, L Lenartowska, M Nowak, et al.
Vaccine|May 25, 2019
Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants - Results from a randomized, double-blind vaccine trialH Nieminen, H Rinta-Kokko, J Jokinen, et al.
Vaccine|September 4, 2017
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2-17-year-old children with asplenia or splenic dysfunction: A phase 3 studyL Szenborn, I V Osipova, H Czajka, et al.
The Nigerian Postgraduate Medical Journal|March 18, 2014
Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian Infants: a randomised trialO O Odusanya, Y A Kuyinu, O A Kehinde, et al.
The Lancet. Respiratory Medicine|August 16, 2014
Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trialA A Palmu, J Jokinen, H Nieminen, et al.
Plos One|August 21, 2015
VSX2 and ASCL1 Are Indicators of Neurogenic Competence in Human Retinal Progenitor CulturesLynda S Wright, Isabel Pinilla, Jishnu Saha, et al.
Human Vaccines & Immunotherapeutics|December 1, 2015
Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized studyA Odutola, M O Ota, E O Ogundare, et al.
American Journal of Human Genetics|January 29, 2019
Gene Augmentation and Readthrough Rescue Channelopathy in an iPSC-RPE Model of Congenital BlindnessPawan K Shahi, Dalton Hermans, Divya Sinha, et al.
Pageof 3